Cellosaurus MDA-MB-231 NAT1+/- 2-12 (CVCL_A9BD)
| Cell line name | MDA-MB-231 NAT1+/- 2-12 |
|---|---|
| Synonyms | CRISPR 2-12 |
| Accession | CVCL_A9BD |
| Resource Identification Initiative | To cite this cell line use: MDA-MB-231 NAT1+/- 2-12 (RRID:CVCL_A9BD) |
| Comments | Group: Triple negative breast cancer (TNBC) cell line. Population: Caucasian. Characteristics: Transfected with a scrambled NAT1 shRNA. Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1 (Note=1 of 2 alleles). Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
| Sequence variations |
|
| Disease | Breast adenocarcinoma (NCIt: C5214) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_A9BA (MDA-MB-231 NAT1 scrambled) |
| Sex of cell | Female |
| Age at sampling | 51Y |
| Category | Cancer cell line |
| Publications | PubMed=32555504; DOI=10.1038/s41598-020-66863-4; PMCID=PMC7299936 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_A9BD |
| Encyclopedic resources | Wikidata; Q108820876 |
| Entry history | |
| Entry creation | 23-Sep-2021 |
| Last entry update | 19-Dec-2024 |
| Version number | 8 |